{
  "inventory": {
    "metformin 500 mg tablets": 60,
    "sitagliptin 25 mg tablets": 10,
    "insulin glargine 100 units/mL 3 mL pen": 12
  },
  "snippets": [
    "Metformin is contraindicated in severe renal impairment (eGFR <30 mL/min/1.73 m²) due to risk of lactic acidosis. Discontinue immediately and review glycaemic management. (BNF Dosing in renal impairment, accessed 20 Jun 2025)",
    "For eGFR 15–30, consider sitagliptin 25 mg daily or insulin; adjust doses according to renal function. (NICE NG28 Type 2 diabetes, 2023 update)"
  ]
}